Qiagen is a Netherlands-based company established in 1984, specializing in the manufacturing sector, particularly within pharmaceuticals. With a workforce of 5,001 to 10,000 employees, the company generates significant revenue, indicating its substantial presence in the industry. Qiagen's expertise is reflected in its focus on molecular analysis, particularly regarding formalin-fixed, paraffin-embedded (FFPE) samples, which are critical for biomedical research. The company has published guides detailing the challenges and methodologies for successful biomarker profiling from FFPE samples, emphasizing factors such as nucleic acid fragmentation and effective deparaffinization techniques. Additionally, Qiagen has produced case studies that explore specific applications of its technologies, such as the analysis of skeletal remains. These documents underscore the company's commitment to advancing molecular diagnostics and research through innovative solutions that address common obstacles in sample processing and analysis. Overall, Qiagen's published materials highlight its role as a key player in the field of molecular biology and diagnostics.